Structure Therapeutics: Funding, Investors & Team (Oct 2026)
Structure Therapeutics develops groundbreaking medications for patients using cutting-edge computational and structure-based technology. Our innovative platform combines advancements in computational chemistry, visualizing molecular interactions, and integrating data to create highly effective oral medications that surpass current limitations in biologic and peptide drugs. We are progressing our pipeline of differentiated, safe treatments targeting chronic diseases with significant unmet needs, such as cardiovascular, metabolic, and pulmonary conditions. With our team's expertise in complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development, we aim to design and deliver top-quality medications with a profound impact on patients and extensive commercial potential.
Structure Therapeutics has raised $1.3B across 2 funding rounds on record, the most recent an undisclosed round of $748M announced in Dec 2025.
That round is above the $8.4M median round size for Biotechnology companies tracked on FundedIQ over the last two years.
Structure Therapeutics Company Profile and Key Stats
Latest funding round on record: Dec 2025.
Structure Therapeutics Funding Rounds
Structure Therapeutics raised $547M in an undisclosed round announced in Jun 2024.
1.5 years later, an undisclosed round of $748M was announced in Dec 2025.
Structure Therapeutics Founders and Leadership Team
Contact details for the Structure Therapeutics team: 1 of 1 has an email address on file.
Start 14-day free trial →Structure Therapeutics Funding Compared to Other Biotechnology Startups
Structure Therapeutics' latest round of $748M is above the median round in Biotechnology. Medians cover the last 24 months of disclosed rounds.
Funded Startups Like Structure Therapeutics in Biotechnology and South San Francisco
Companies Similar to Structure Therapeutics
Prolific Machines is a biotech company located in San Francisco, California, that was established in 2020. It…
Altay Therapeutics is a biotech company focused on finding and discovering small molecule therapies for…
Kallyope, we believe that the gut is the gateway to our internal world. Containing millions of neurons, the…
Astrocyte Pharmaceuticals is a drug development company that helps in the recovery and well-being of brain…
Tiny Health offers a gut health test specifically designed for mothers and babies aged 0 to 3 years.…
Junevity is dedicated to using cutting-edge transcription factor medicines to combat age-related diseases.…
Arkea Bio creates technology aimed at reducing greenhouse gas (GHG) emissions in the agricultural sector.
Serán is a contract development and manufacturing organization providing a comprehensive suite of…
Precision’s goal is to provide breakthrough treatments for the one billion patients worldwide suffering from…
Enveda is a biotechnology company that utilizes AI-powered tools to explore and characterize molecules from…
Avery Therapeutics, Inc. is a company dedicated to developing tissue engineered therapeutics to treat…
Structure Therapeutics Funding FAQs
What does Structure Therapeutics do?
Structure Therapeutics develops groundbreaking medications for patients using cutting-edge computational and structure-based technology. Our innovative platform combines advancements in computational chemistry, visualizing molecular interactions, and integrating data to create highly effective oral medications that surpass current limitations in biologic and peptide drugs. We are progressing our pipeline of differentiated, safe treatments targeting chronic diseases with significant unmet needs, such as cardiovascular, metabolic, and pulmonary conditions. With our team's expertise in complex biological targets and mechanisms, structure-based drug design, and global drug discovery and development, we aim to design and deliver top-quality medications with a profound impact on patients and extensive commercial potential.
How much funding has Structure Therapeutics raised?
Structure Therapeutics has raised $1.3B across 2 rounds on record. The most recent is an undisclosed round of $748M announced in Dec 2025.
When did Structure Therapeutics last raise funding?
Structure Therapeutics' most recent funding round on record is an undisclosed round of $748M, announced in Dec 2025.
Who founded Structure Therapeutics?
FundedIQ lists Raymond Stevens (Founder) at Structure Therapeutics.
Where is Structure Therapeutics headquartered?
Structure Therapeutics is based in South San Francisco, California, United States.
How many employees does Structure Therapeutics have?
Structure Therapeutics is in the 101-250 employee band.
How does Structure Therapeutics' funding compare to other Biotechnology startups?
Structure Therapeutics' latest round of $748M is above the $8.4M median round size for Biotechnology companies on FundedIQ across 4,185 tracked companies over the last two years.
About FundedIQ's Structure Therapeutics Funding Data
FundedIQ tracks announced funding rounds and refreshes this profile every week. Round dates, stages and amounts are normalised to a single format, converted to US dollars, and de-duplicated: two records of the same round announced days apart are merged, and two genuinely different rounds are kept apart on the amounts they disclose. Amounts shown are the disclosed figures only — a round announced without a number is listed and excluded from the total rather than estimated.
Employee counts are reported bands, not exact headcounts. Founder and executive names carry the job title on record. Anything we do not hold for Structure Therapeutics is left off this page rather than filled in.
Know who just raised. Then know who to reach.
Startup funding intelligence on every funded startup: the round, the investors and the founders, as a file in your inbox or searchable in the app.
Radar from $49/mo · Pro from $149/mo. Card required, nothing charged until day 15, and we email you 3 days before that. Need something specific? Custom plans from $499/mo.